Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros

Ryota Masuzaki, Haruhiko Yoshida, Masao Omata

研究成果: ジャーナルへの寄稿記事査読

7 被引用数 (Scopus)

抄録

Hepatitis C virus (HCV) infection, which seems to have spread worldwide recently, is now the leading cause of hepatocellular carcinoma (HCC) development in various geographic areas. The primary prevention of HCV-related HCC includes strategies for the prevention of HCV infection and those for viral eradication. Even after HCC development, short-term prognosis of patients has been much improved recently due to advances in early diagnosis and treatment. However, long-term prognosis is as yet far from satisfactory due to frequent recurrence of HCC even after apparently curative treatment, either local ablation or surgical resection. At least theoretically, strategies similar to those of primary prevention may be applicable to HCC recurrence. In this review, we summarized the reported favorable effects of chemotherapy on primary and tertiary prevention of HCC.

本文言語英語
ページ(範囲)S281-S286
ジャーナルDigestive and Liver Disease
42
SUPPL. 3
DOI
出版ステータス出版済み - 7月 2010
外部発表はい

フィンガープリント

「Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル